IGF-1 LR3: Handling, Storage, and Reconstitution Guide

Sound IGF-1 LR3 handling and storage practice protects the integrity of a lyophilized research protein of roughly 9 kDa that is more sensitive to preparation stress than a small peptide. This guide covers laboratory best practice for storage, reconstitution for in-vitro preparation, aliquoting, and documentation. It describes laboratory workflows only and is not human-use guidance.

IGF-1 LR3 Handling and Storage Fundamentals

IGF-1 LR3 ships as a white lyophilized powder in a sealed glass vial, typically offered in 0.1 mg and 1 mg presentations at a reported purity of 99 percent or greater. The starting point for good handling is to keep material sealed, cool, dry, and shielded from light until it is prepared. Because the analog is a larger protein, minimizing physical stress during handling is part of preserving batch quality.

Careful sourcing and handling connect directly to the mechanistic and applied work described in the IGF-1 LR3 mechanism of action and the IGF-1 LR3 research applications, where reproducibility depends on stable, well-characterized material.

Before any material is opened, it is good practice to confirm that the vial, lot, and presentation match the accompanying documentation and that the powder appears as an intact lyophilized cake or pellet. Inspecting the vial on receipt and recording its condition establishes a baseline that makes it easier to attribute any later variability to a specific handling step rather than to the incoming material.

Recommended Storage Conditions

Store lyophilized IGF-1 LR3 sealed at 25 degrees Celsius or below, away from heat, light, and moisture. For extended storage, keep the material lyophilized and refrigerated or frozen. Maintaining consistent conditions across a study period, rather than cycling material through varying temperatures, supports both stability and reproducibility.

• Sealed lyophilized vial, protected from heat, light, and humidity.
• Refrigerated or frozen storage for extended holding periods.
• Storage records maintained as part of routine quality assurance.

Reconstitution for In-Vitro Preparation

For laboratory preparation, lyophilized material is typically reconstituted with bacteriostatic water or another solvent appropriate to the assay. Larger proteins can be sensitive to agitation, so add the solvent gently down the vial wall rather than directly onto the powder, and allow the material to dissolve without vigorous shaking or vortexing. Reconstitution is a bench procedure for producing in-vitro working stocks, not an administration step.

Concentration calculations rest on the reported vial mass and the analog's molecular weight of approximately 9117.60 g/mol. Verifying identity and content through the certificate of analysis before relying on a prepared stock is good practice for a protein of this size.

Aliquoting and Freeze-Thaw Management

Reconstituted IGF-1 LR3 is less stable than the lyophilized powder, so dividing the solution into single-use aliquots limits repeated freeze-thaw cycles, a common cause of protein degradation. Label each aliquot with compound, concentration, and date, keep reconstituted material refrigerated, and use it within the timeframe indicated by your protocol. These practices mirror the handling logic used for related compounds such as the Tesamorelin handling guide.

Lot and Certificate of Analysis Verification

Every IGF-1 LR3 batch ships with a third-party-verified certificate of analysis. It documents purity by HPLC or reverse-phase chromatography, mass-spectrometry identity confirmation, and the lot number, testing date, and method. Record the lot against your experimental records so results can be traced back to a specific batch, which is central to defensible data for a recombinant analog of this complexity.

Sample COAs can be requested ahead of purchase to confirm testing parameters, and researchers are encouraged to perform independent verification. The same COA discipline applies across the growth-regenerative catalog, as noted in the Follistatin handling guide.

Documentation and Traceability

Follow institutional SOPs, chemical hygiene plans, and approved protocols, and wear appropriate PPE such as a lab coat, gloves, and eye protection, with engineering controls in place. Record lot numbers, storage conditions, and handling activities, and retain COAs and batch documentation to support traceability and audit readiness. Current batch documentation is available on the IGF-1 LR3 product page.

For research use only. IGF-1 LR3 is an investigational research peptide and is not approved for human or veterinary use. All handling described here refers to laboratory preparation for in vitro and preclinical research.